A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies

Name: A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies
License: Public Domain

Seagen Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

cell disease large non

disease, hodgkin, lymphoma, large-cell, anaplastic, lymphoma, non-hodgkin

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 481747
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.